Management of Status Epilepticus

Publish Year: 1398
نوع سند: مقاله کنفرانسی
زبان: English
View: 343

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

EPILEPSEMED16_048

تاریخ نمایه سازی: 28 بهمن 1398

Abstract:

Status epilepticus is a medical emergency that requires rapid and vigorous treatment to prevent neuronal damage and systemic complications. Failure to diagnose and treat status epilepticus accurately and effectively results in significant morbidity and mortality. The most common subtype is generalized tonic-clonic status epilepticus. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition. Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. Therapy should proceed simultaneously on four fronts: termination of seizures; prevention of seizure recurrence once status is controlled; management of precipitating causes of status epilepticus; management of the complications Refractory and super-refractory status epilepticus (SE) are serious illnesses with a high risk of morbidity and even fatality. In the setting of refractory generalized convulsive SE (GCSE), there is ample justification to use continuous infusions of highly sedating medications. Forms of SE other than GCSE (and its continuation in a subtle or nonconvulsive form) should usually be treated far less aggressively, often with non- sedating anti-seizure drugs (ASDs). Management of non-classic NCSE in ICUs is very complicated and controversial, and some cases may require aggressive treatment. Continuous EEG monitoring is crucial in guiding the management of these critically ill patients: in diagnosis, in detecting relapse, and in adjusting medications. The morbidity and mortality of RSE is substantial, but many patients survive and even return to normal function, so RSE should be treated promptly and as aggressively as the individual patient and type of SE indicate.

Keywords:

Status epilepticus , Refractory and super-refractory status epilepticus

Authors

Hossein Kahnouji

Neurologist, Epilepsy Fellowship